用途:1、一种有效的JAK1/2抑制剂,IC50 分别为3.3 nM/2.8 nM，比JAK3选择性高130倍。Ruxolitinib is an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, w..

湖北魏氏化学分析试剂—现货供应商

随货质检单和图谱资料,下单及时快递发货

技术服务 刘欢 13125137732 QQ 2853863890